News|Articles|March 26, 2025
Develop Potency Assays Early for ATMP Success
Author(s)Charles River
Early potency assay development and MOA understanding are critical for ATMP success. Delays can increase costs and risk failure, but recent advances highlight the need for timely, validated approaches to ensure regulatory and commercial success.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Industry Experts Probe CNPV Impacts: Part II
2
How New ADC Modalities Backed by Samsung Could Shape Solid Tumor Treatment
3
What a $2 Billion Maryland Expansion Means for the Future of Biologics Production
4
How Miniaturized Analytics Are Transforming Aseptic Bioprocessing Control
5
